You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR CLOMIPHENE CITRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CLOMIPHENE CITRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00005104 ↗ Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome Completed University of Virginia N/A 2000-01-01 OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
NCT00005104 ↗ Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome Completed National Center for Research Resources (NCRR) N/A 2000-01-01 OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
NCT00005654 ↗ Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome Completed University of Virginia N/A 2000-01-01 OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene or spontaneous ovulation in obese women with polycystic ovary syndrome.
NCT00005654 ↗ Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome Completed National Center for Research Resources (NCRR) N/A 2000-01-01 OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene or spontaneous ovulation in obese women with polycystic ovary syndrome.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CLOMIPHENE CITRATE

Condition Name

Condition Name for CLOMIPHENE CITRATE
Intervention Trials
Infertility 59
Polycystic Ovary Syndrome 50
Anovulation 14
Polycystic Ovarian Syndrome 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CLOMIPHENE CITRATE
Intervention Trials
Infertility 84
Polycystic Ovary Syndrome 80
Syndrome 48
Anovulation 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CLOMIPHENE CITRATE

Trials by Country

Trials by Country for CLOMIPHENE CITRATE
Location Trials
United States 100
Egypt 55
Italy 10
China 9
Brazil 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CLOMIPHENE CITRATE
Location Trials
Texas 7
New York 7
Michigan 6
California 6
Pennsylvania 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CLOMIPHENE CITRATE

Clinical Trial Phase

Clinical Trial Phase for CLOMIPHENE CITRATE
Clinical Trial Phase Trials
Phase 4 50
Phase 3 27
Phase 2/Phase 3 10
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CLOMIPHENE CITRATE
Clinical Trial Phase Trials
Completed 95
Unknown status 32
Not yet recruiting 16
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CLOMIPHENE CITRATE

Sponsor Name

Sponsor Name for CLOMIPHENE CITRATE
Sponsor Trials
Cairo University 15
Ain Shams University 12
Assiut University 10
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CLOMIPHENE CITRATE
Sponsor Trials
Other 243
Industry 17
NIH 8
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.